Prostate Cancer Clinical Trials in San Antonio, TX

Prostate Cancer Clinical Trials in San Antonio, TX

View the best 10 prostate cancer medical studies in San Antonio, Texas. Access promising new therapies by applying to a San Antonio-based Prostate Cancer clinical trial.

Trials in San Antonio, Texas

Here are the top 10 medical studies for prostate cancer in San Antonio, Texas

Image of Urological Associates of Southern Arizona, P.C . in Tucson, United States.


BCL-2 Inhibitor

Recruiting1 awardPhase 1
This trial is testing a new drug to treat adult patients with small cell lung cancer, castration resistant prostate cancer, or follicular lymphoma who have relapsed or are refractory to standard therapies.
Image of Exelixis Clinical Site #53 in Gilbert, United States.

Cabozantinib +1 More

Tyrosine Kinase Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing the safety and effectiveness of a new cancer drug when used in combination with another cancer drug. The new drug is being tested on people with different types of cancer, including bladder, kidney, prostate, and breast cancer.
Image of Research Site in Lakewood, United States.

Capivasertib +1 More

AKT Inhibitor

Recruiting1 awardPhase 3
This trial will compare the effect of two different treatments for metastatic prostate cancer. One group will receive a combination of capivasertib and docetaxel, while the other group will receive docetaxel and a placebo. The goal is to see if adding capivasertib to docetaxel improves survival rates.
Image of Urologic Surgeons of Washington in Washington, United States.

HC-1119 +1 More


Recruiting2 awardsPhase 3
This trial is a study to compare the effectiveness and safety of a new oral medication, HC-1119, to a current standard of care medication, enzalutamide, in men with asymptomatic or mildly symptomatic prostate cancer that has progressed despite treatment with prior hormone therapy.
Image of Research Site in Tucson, United States.

AZD5305 +1 More

Hormone Therapy

Recruiting1 awardPhase 3
This trial tests a new drug for advanced prostate cancer to see if it can slow down the spread of the disease.
Image of Urology Centers Of Alabama in Homewood, United States.

Niraparib +2 More

PARP Inhibitor

Recruiting1 awardPhase 3
This trial will compare the effect of two different treatments on metastatic prostate cancer patients.
Image of Houston Metro Urology in Houston, United States.

Radiotherapy +1 More


Recruiting2 awardsPhase 3
This triallooks at if adding a drug to radiation and hormone therapy can delay the spread of cancer in the body.
Image of Weill Cornell Medical College in New York, United States.


XPO1 inhibitor

Recruiting1 awardPhase 1 & 2
This trial will assess the safety, tolerability, and preliminary efficacy of KPT-8602, an oral XPO1 inhibitor, in patients with relapsed/refractory multiple myeloma, metastatic colorectal cancer, metastatic castration resistant prostate cancer, higher risk myelodysplastic syndrome, acute myeloid leukemia, and newly diagnosed intermediate/high-risk MDS.
Image of University of Alabama at Birmingham (UAB) in Birmingham, United States.

Standard of Care Proton Therapy +3 More

Proton Beam Therapy

Recruiting1 award
This trial compares the quality of life, toxicity, and disease control of men with prostate cancer treated with proton therapy vs. IMRT.
Image of START Midwest in Grand Rapids, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is testing a new drug, NGM831, as a possible treatment for advanced or metastatic solid tumors.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.